Net profit increased 118.11% year on year! Nutrichem’s performance in 2022 is very good
On February 24, Nutrichem released a performance bulletin, the company in 2022 from January to December to achieve operating revenue of 8.191 billion yuan, a year-on-year growth of 11.39%, the net profit attributable to shareholders of listed companies was 1.049 billion yuan, up 118.11% year on year
During the reporting period, the company's operating income is expected to be RMB 8,191,000,371.69, an increase of 11.39% over the same period last year. Net profit attributable to shareholders of listed companies is estimated to be RMB 1,049,085,089.75, an increase of 118.11% over the same period last year. Net profit attributable to shareholders of listed companies excluding non-recurring gains and losses is estimated to be RMB 1,070,385,527.76, an increase of 114.13% over the same period last year. Basic earnings per share is expected to be 0.86 yuan, up 120.51% from the same period last year.
At the end of the report period, the total assets of the Company are estimated to be 12,507,539,504.26 yuan, an increase of 4.74% compared to the beginning of the period; The owner's equity attributable to the shareholders of the listed company is estimated to be RMB 5,850,621,632.10, an increase of 21.01% over the beginning of the period. Net asset value per share attributable to shareholders of the listed company is expected to be 4.77 yuan, an increase of 21.07% from the beginning of the period.
During the reporting period, the company's revenue scale continued to increase, product profitability improved, and investment income and exchange income increased significantly year-on-year, achieving a significant increase in the reporting period net profit attributable to shareholders of listed companies and net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses.
The main reason for the increase in performance
During the reporting period, focusing on strategic planning and annual business objectives, the company made efforts to overcome the adverse factors such as repeated epidemic, inflation, Russia-Ukraine war and rising raw material prices, grasped the market opportunity, guaranteed the supply of raw materials, stabilized the output of production capacity, consolidated and deepened market sales, dynamically guaranteed the profit space of products, and achieved a record high in business performance. In addition, the investment income attributable to the company in the current period increased year on year. Influenced by the appreciation of the US dollar, the exchange income attributable to the company in the current period also increased correspondingly. Better investment income and exchange income also enhanced the company's performance.
2026-09-21
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Renaissance BioScience Receives Genome BC Funding to Extend RNAi Biopesticide Platform to Target Soil-Dwelling Crop Pests
-
The project with an investment of ¥105 million and an annual output of 4000 tons of Propargite is to be built
-
Brazil's Agriconnection uses a new model to import and direct sell pesticides, with revenue exceeding $340 million
-
The Indian biopesticide market will grow at a CAGR of 9.38%
-
China's insecticide import and export data for June
-
Jiangsu TrustChem’s degradable pesticide packaging bottle won the domestic and international invention patent authorization
-
Hebang Biological intends to increase its stake in Australian listed company AEV and achieve control
-
The operating rate of Brazil's chemical industry has deteriorated: at just 58%, the latest figure is the lowest since 1990
-
Adama President and CEO Change! He took office on October 1
-
BAL became the first local company in India to register a 96% Haloxyfop-R-methyl ester Technical
Recommend Reading
-
Roche Keeps German Diagnostics Investment
-
AstraZeneca’s Wainua Fails Phase III Heart Trial, Wiping Out About $27 Billion in Market Value
-
Pregabalin vs Gabapentin: Differences, Uses, and Side Effects
-
Lotte Merges with HD Hyundai: Can Korea’s Petrochemical First Case Trigger True Restructuring?
-
Shin-Etsu Chemical Invests $218 Million in Rare Earth Refinery as Multiple Countries Accelerate Domestic Production
-
End-of-Month Maleic Anhydride Market Trends Primarily Consolidating
-
Strong Demand Drives Slight Rise in Toluene Market in November
-
ICIS Global No.58: ECHEMI Again Ranks Among the World’s Chemical Distributors
-
Narrow Fluctuations in the Ethanol Market in China in November
-
November Sodium Metabisulfite Price Increase